About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
Hodgkin Lymphoma - Immunotherapy
By
Stephen M. Ansell
9 Videos
188 views
November 12, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Related Content
AUTOPLAY
ON
08:59
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "SWOG S1826 Trial - Nivo-AVD vs. Bv-AVD in O…
Feat.
S. Rutherford
41:20
SOHO Highlights: State of the Art and Next Questions
SOHO Highlights - State of the Art & Next Questions: Hodgkin Lym…
Feat.
N. Bartlett
15:18
UNC Lineberger Comprehensive Cancer Center
Hodgkin Lymphoma Management: Updates for 2023
Feat.
N. Grover
30:24
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment of Older Patients With HL in the …
Feat.
A. Evens
42:09
University of Colorado Department of Medicine
Immunotherapy in Lymphomas: The Present and the Future
Feat.
M. Kamdar
15:24
Total Health
2023 ASCO® Direct Philadelphia: Hodgkin Lymphoma Updates
Feat.
J. Svoboda
10:21
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: HL
Feat.
A. Herrera
08:21
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "The Phase 2 KEYNOTE-B68 Trial - Efficacy …
Feat.
A. Mcdonald
15:56
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
2024 Updates in Management of Hodgkin Lymphoma
Feat.
J. Svoboda
08:30
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "PD-1 Blockade Before AutoSCT in R/R Classic…
Feat.
S. Desai
15:19
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Treatment of HL in Older Adults
Feat.
J. Friedberg
36:24
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Hodgkin Lymphoma
Feat.
A. Herrera
21:46
SOHO Turkey 2023
SOHO Turkey 2023: How I Treat Hodgkin Lymphoma
Feat.
T. Toptas
06:50
ecancer
ASCO® 2023 Insights: "S1826 Study Summary - Nivolumab-AVD vs. B…
Feat.
A. Herrera
31:25
Indy Hematology Review
Jumping on a Moving Bullet Train: Emerging Treatments for Hodgkin Ly…
Feat.
M. Lunning
15:23
EHA 2022 Conference Coverage
Improved OS With 1L Brentuximab Vedotin + Chemo in Stage III/IV Clas…
Feat.
J. Radford
19:27
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient
Updates in Management of Hodgkin Lymphoma
Feat.
J. Svoboda
19:51
UChicago Medicine
Update on Immunotherapy Efforts in cHL and DLBCL
Feat.
J. Kline
13:38
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "S1826 Trial - Nivo-AVD Compared to Brentuxi…
Feat.
S. Castellino
26:18
MyCancerHaven
Overview of the Diagnosis and Treatment of Hodgkin Lymphoma
Feat.
R. Vij,
T. Fenske
